Physician profile
J Mark Morales
NPI 1134170657
$103,493.81
in general payments reported to CMS, 2019-2025
19 companies · $22K in 2025
The $22K reported for 2025 was more than what 94% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $15K · 2021: $15K · 2022: $597 · 2023: $17K · 2024: $23K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $58K · Food and Beverage: $4,298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $58,012.20 |
| Food and Beverage | $4,297.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $58,012.20 | 2023-2025 | Sternalock, Sternalock 360 System, Cable-Ready |
| Jace Medical LLC | $36,508.14 | 2019-2021 | |
| Atricure, INC. | $2,964.75 | 2019-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System, Synergy Ablation System |
| Getinge USA Sales, LLC | $2,511.52 | 2019-2025 | Heartstring III Proximal Seal, Axius Coronary Shunt, Acrobat-I Stabilizer |
| Elutia, INC. | $715.73 | 2019-2022 | |
| Edwards Lifesciences Corporation | $641.62 | 2022-2025 | Mitris Resilia Mitral Valve |
| Abiomed | $628.69 | 2022-2025 | Impella |
| Medtronic Vascular, INC. | $314.48 | 2020 | |
| Lemaitre Vascular, INC. | $169.98 | 2019 | |
| Baxter Healthcare | $166.77 | 2019-2021 | |
| Abbvie INC. | $147.84 | 2023-2024 | |
| Medtronic, INC. | $144.82 | 2024-2025 | Corevalve Evolut R, Cg Future |
| Shockwave Medical, INC | $139.44 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lsi Solutions INC | $111.51 | 2020 | |
| Biostable Science & Engineering | $92.80 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcym INC | $71.29 | 2021-2022 | |
| Abbott Laboratories | $66.63 | 2021 | |
| Aroa Biosurgery Incorporated | $64.95 | 2024 | |
| Clearflow INC. | $20.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw J Morales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.